申请人:Van Zandt Michael
公开号:US20120129806A1
公开(公告)日:2012-05-24
Compounds according to Formula I are potent inhibitors of Arginase I and II activity:
where R
1
, R
2
, R
3
, R
4
, D, W, X, Y, and Z are defined in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use in treating or preventing a disease or a condition associated with arginase activity.
根据公式I,化合物是Arginase I和II活性的强效抑制剂:其中R1、R2、R3、R4、D、W、X、Y和Z在规范中定义。本发明还提供了这些化合物的药物组合物及其在治疗或预防与Arginase活性相关的疾病或病状的方法。